Vaxart Inc (VXRT)
Sector • Healthcare Industry • Biotechnology & Pharmaceuticals |
Industry • Biotechnology & Pharmaceuticals |
Sector • Healthcare |
News
Vaxart*s Gamechanger: $9.27M BARDA Award Fuels Phase 2b Trials for Pioneering Oral COVID-19 Vaccine
Vaxart*s Strategic Funding Move Bolsters Its Position in the Competitive Market
Vaxart Inc Surpasses Expectations with $2.101 Million in Revenue in Recent Fiscal Period
Vaxart Inc announced Revenue of $1.358 million, in the April to June 30 2023